A Real-World Registry Investigating TReprostInil sodiUM in Pulmonary Hypertension (Re-TRIUMPH)

Study Of Right Ventricular Performance In PAH Patients Treated With Rapid Dose Treprostinil (Remodulin)

NCT02074449 ·Status: COMPLETED

Remodulin® to Oral Treprostinil Transition

NCT01588405 ·Status: COMPLETED ·Phase: PHASE2

A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Treprostinil Palmitil Inhalation Powder in Participants With Pulmonary Arterial Hypertension

NCT05147805 ·Status: COMPLETED ·Phase: PHASE2

An Open-Label, Long-Term Study of Oral Treprostinil in Subjects With Pulmonary Arterial Hypertension

NCT01560637 ·Status: COMPLETED ·Phase: PHASE3

Efficacy and Safety of Triple-targeted Drug Therapy in Treatment-naive Patients With Non-low-risk PAH: A Real-world, Multicenter Study

NCT06753981 ·Status: RECRUITING

Open-label, Clinical Study to Evaluate the Safety and Tolerability of TreT in Subjects With PAH Currently Using Tyvaso

NCT03950739 ·Status: COMPLETED ·Phase: PHASE1

Phase III Randomized Study of UT-15 in Patients With Primary Pulmonary Hypertension

NCT00004497 ·Status: COMPLETED ·Phase: PHASE3

Efficacy of Triple-Combination Therapy in Severe PAH-CHD

NCT06196801 ·Status: ACTIVE_NOT_RECRUITING

An Open-Label Extension Trial of UT-15C Sustained-release (SR) in Subjects With Pulmonary Arterial Hypertension

NCT01027949 ·Status: COMPLETED ·Phase: PHASE3

Safety and Efficacy of Inhaled Treprostinil in Patients With PAH

NCT01557647 ·Status: WITHDRAWN ·Phase: PHASE3

Inhaled Treprostinil in Participants With Pulmonary Hypertension Due to Chronic Obstructive Pulmonary Disease (PH-COPD)

NCT03794583 ·Status: TERMINATED ·Phase: PHASE3

A Study to Evaluate the Safety and Tolerability of Treprostinil Palmitil Inhalation Powder in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease

NCT05176951 ·Status: COMPLETED ·Phase: PHASE2

Efficacy and Safety of Treprostinil in Intermediate-Risk Pulmonary Arterial Hypertension

NCT07177703 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

Efficacy and Tolerability of Subcutaneously Administered Treprostinil Sodium in Patients With Severe (Non-operable) Chronic Thromboembolic Pulmonary Hypertension (CTREPH)

NCT01416636 ·Status: COMPLETED ·Phase: PHASE3

Repurposing a Histamine Antagonist to Benefit Patients With Pulmonary Hypertension

NCT03554291 ·Status: COMPLETED ·Phase: PHASE2

Safety, Efficacy and Treatment Satisfaction in Patients With PAH Rapidly Switched From Epoprostenol to Remodulin

NCT00373360 ·Status: COMPLETED ·Phase: PHASE4

rhBNP in Type 3 Pulmonary Hypertension

NCT05716984 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE4

Retrospective Data Analysis of Data From the Zurich PH Registry

NCT03198910 ·Status: COMPLETED

A Dose Response Study of UT-15C SR in Patients With Exercise-Induced Pulmonary Hypertension

NCT01104870 ·Status: COMPLETED ·Phase: PHASE2

Trimetazidine in Pulmonary Artery Hypertension

NCT02102672 ·Status: UNKNOWN ·Phase: PHASE2

Phase III Clinical Worsening Study of UT-15C in Subjects With PAH Receiving Background Oral Monotherapy

NCT01560624 ·Status: COMPLETED ·Phase: PHASE3

Real World Observational Study of Sotatercept for Pulmonary Hypertension

NCT06751082 ·Status: RECRUITING

A Study on the Efficacy and Safety of Empagliflozin in the Treatment of Pulmonary Arterial Hypertension

NCT06554301 ·Status: RECRUITING ·Phase: PHASE1

Simvatstatin Used to Treat Pulmonary Hypertension

NCT00538044 ·Status: UNKNOWN ·Phase: PHASE1

Effect of BIA 5-1058 on the Steady State Pharmacokinetics of Treprostinil

NCT04675944 ·Status: COMPLETED ·Phase: PHASE1